Department of Surgery, Ascension St. John Hospital, 22101 Moross Rd, Detroit, MI, 48236, USA; Beaumont Hospital Grosse Pointe, 468 Cadieux Rd, Grosse Pointe, MI, 48230, USA.
Department of Surgery, Ascension St. John Hospital, 22101 Moross Rd, Detroit, MI, 48236, USA.
Am J Surg. 2021 Mar;221(3):581-584. doi: 10.1016/j.amjsurg.2020.11.010. Epub 2020 Nov 9.
Dual intragastric balloon (DIGB) therapy is a non-surgical, restrictive method of weight loss. We evaluated weight loss and patient satisfaction after DIGB removal.
Between 2016 and 2019, 35 patients had DIGB therapy. A retrospective review of weight loss at balloon removal and follow-up, adverse events during DIGB therapy, and patient satisfaction was performed.
At follow-up after balloon removal (22.3 ± 10.5 months), mean percent excess weight loss (%EWL) was significantly decreased compared to %EWL at removal (4.7 ± 42.7% vs 32.4 ± 38.8%, p = .001). Weight regain occurred in 22/31 (71%) patients. Adverse events during DIGB therapy included: nausea, abdominal pain, reflux, pancreatitis, and gastric outlet obstruction. Twenty-five (71.4%) patients completed a satisfaction questionnaire. Only 3/25 (12%) patients were satisfied, and 92% would not choose DIGB for weight loss.
Weight loss achieved from DIGB on average was not maintained after balloon removal. Most patients were not satisfied and would not choose DIGB again.
双胃内球囊（DIGB）疗法是一种非手术、限制体重的方法。我们评估了 DIGB 去除后的体重减轻和患者满意度。
在 2016 年至 2019 年间，有 35 名患者接受了 DIGB 治疗。对 DIGB 治疗期间的体重减轻和随访、不良事件以及患者满意度进行了回顾性分析。
在球囊去除后的随访中（22.3±10.5 个月），与去除时的%EWL 相比，平均%EWL 明显降低（4.7±42.7% vs 32.4±38.8%，p=0.001）。22/31（71%）名患者出现体重反弹。DIGB 治疗期间的不良事件包括：恶心、腹痛、反流、胰腺炎和胃出口梗阻。25（71.4%）名患者完成了满意度问卷。只有 3/25（12%）名患者满意，92%的患者不会选择 DIGB 进行减肥。
DIGB 平均减轻的体重在球囊去除后无法维持。大多数患者不满意，不会再次选择 DIGB。
